Breaking News Instant updates and real-time market news.

VRTX

Vertex

$177.40

2.38 (1.36%)

15:50
08/07/18
08/07
15:50
08/07/18
15:50

Vertex announces FDA approval of ORKAMBI to treat cystic fibrosis

Vertex announced the U.S. FDA has approved ORKAMBI to include use in children ages 2 through 5 years with cystic fibrosis who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF in this population. ORKAMBI oral granules are available in two dosage strengths for weight-based dosing. ORKAMBI oral granules should be available for fulfillment within 2 to 4 weeks. ORKAMBI was already approved in the U.S. for the treatment of CF in patients ages 6 and older who have two copies of the F508del-CFTR mutation. A Marketing Authorization Application line extension for ORKAMBI in children ages 2 through 5 years has been submitted to the European Medicines Agency with a decision anticipated in the first half of 2019.

  • 30

    Aug

  • 31

    Aug

VRTX Vertex
$177.40

2.38 (1.36%)

07/26/18
OPCO
07/26/18
NO CHANGE
Target $200
OPCO
Outperform
Vertex price target raised to $200 from $180 at Oppenheimer
Oppenheimer analyst Hartaj Singh raised his price target for Vertex to $200 from $180 on "robust" Q2 results and accelerating pipeline. The analyst reiterates an Outperform rating on the shares.
07/26/18
BMOC
07/26/18
NO CHANGE
Target $204
BMOC
Outperform
Vertex price target raised to $204 from $191 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Vertex to $204 and kept his Outperform rating after "stellar" Q2 results that "easily" beat consensus due to the strong Symdeko sales. The analyst notes that Symdeko appears to be "capturing Orkambi switchers as well as naive patients and Orkambi dropouts", adding that its updated revenue guidance is likely to prove conservative on Symdeko's expansion potential.
07/27/18
PIPR
07/27/18
NO CHANGE
Target $230
PIPR
Overweight
Piper says Vertex faces 'onerous task' getting reimbursement for Symkevi in EU
After the EMA announced earlier that the CHMP adopted a positive opinion on Symkevi, Piper Jaffray analyst Edward Tenthoff said he expects EMA approval within the next few months, after which Vertex will face the "onerous task" of gaining European reimbursement. The analyst, who anticipates KALYDECO and ORKAMBI label expansions with PDUFA dates in August to continue to drive CF sales growth this year, keeps his Overweight rating and $230 price target on Vertex shares.
08/07/18
STFL
08/07/18
INITIATION
Target $200
STFL
Buy
Vertex transferred with a Buy at Stifel
Stifel transferred coverage of Vertex to analyst Paul Matteis, who set a Buy rating and $200 price target on the shares. Matteis thinks Vertex continues to build strong barriers to entry that in Cystic Fibrosis and believes that the company's non-CF pipeline largely represents upside to the stock.

TODAY'S FREE FLY STORIES

SCGLY

Societe Generale

$0.00

(0.00%)

12:56
11/19/18
11/19
12:56
11/19/18
12:56
Hot Stocks
Societe Generale says $1.3B settlement covered by provision for disputes »

Societe Generale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.47

-1.01 (-6.98%)

12:55
11/19/18
11/19
12:55
11/19/18
12:55
Options
Bilibili put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

12:55
11/19/18
11/19
12:55
11/19/18
12:55
General news
Treasury Action: yields rolled over from highs »

Treasury Action: yields…

TWTR

Twitter

$32.25

-1.45 (-4.30%)

12:49
11/19/18
11/19
12:49
11/19/18
12:49
Periodicals
Twitter de-emphasize follower counts in iOS redesign, Verge says »

The follower count on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PBR

Petrobras

$14.60

-0.27 (-1.82%)

12:46
11/19/18
11/19
12:46
11/19/18
12:46
Periodicals
Petrobras' Branco says BR Distribuidora not a natural fit, Reuters says »

Incoming Petrobras CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.20

0.35 (0.31%)

12:45
11/19/18
11/19
12:45
11/19/18
12:45
Options
Eli Lilly call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

INGN

Inogen

$137.12

-4.73 (-3.33%)

, RMD

ResMed

$102.53

-1.58 (-1.52%)

12:43
11/19/18
11/19
12:43
11/19/18
12:43
Recommendations
Inogen, ResMed analyst commentary  »

Mobi looks…

INGN

Inogen

$137.12

-4.73 (-3.33%)

RMD

ResMed

$102.53

-1.58 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

MDT

Medtronic

$90.66

-3.02 (-3.22%)

12:35
11/19/18
11/19
12:35
11/19/18
12:35
Options
Medtronic put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:34
11/19/18
11/19
12:34
11/19/18
12:34
Hot Stocks
Societe Generale agrees to pay $1.34B for violations of U.S. sanctions »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

12:30
11/19/18
11/19
12:30
11/19/18
12:30
Periodicals
China's WTO envoy says China to propose WTO changes, Reuters says »

Zhang Xiangchen,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26
Periodicals
White House still seeking to take Jim Acosta's press pass away, WSJ says »

The White House is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

PEP

PepsiCo

$118.30

-0.09 (-0.08%)

12:25
11/19/18
11/19
12:25
11/19/18
12:25
Options
PepsiCo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

AAL

American Airlines

$35.36

-1.38 (-3.76%)

12:22
11/19/18
11/19
12:22
11/19/18
12:22
Hot Stocks
APA seeks to open contract negotiations with American Airlines »

The Allied Pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRLCY

L'Oreal

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Hot Stocks
L'Oreal appoints of Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMX

Aevi Genomics Medicine

$1.12

-0.04 (-3.45%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Conference/Events
Aevi Genomics Medicine management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$21.82

-0.43 (-1.93%)

12:15
11/19/18
11/19
12:15
11/19/18
12:15
Options
Teva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

PRT

PermRock Royalty Trust

$10.75

-1.3 (-10.79%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
PermRock Royalty Trust falls -10.9% »

PermRock Royalty Trust is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$23.54

-4.46 (-15.93%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Colfax falls -15.9% »

Colfax is down -15.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SPB

Spectrum Brands

$47.10

-12.26 (-20.65%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Spectrum Brands falls -20.7% »

Spectrum Brands is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ZAYO

Zayo Group

$25.98

2.285 (9.64%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Zayo Group rises 9.8% »

Zayo Group is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

REN

Resolute Energy

$34.93

4.42 (14.49%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Resolute Energy rises 14.7% »

Resolute Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.95

-0.115 (-0.95%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Options
35K US Oil Fund Jan 11 - 11.5 put spreads trade 16c on ISE »

35K US Oil Fund Jan 11 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$175.00

23 (15.13%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 16.1% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.